LLY logo

Eli Lilly and Company (LLY) Accounts receivable

Annual accounts receivable:

$11.01B+$1.92B(+21.07%)
December 31, 2024

Summary

  • As of today (May 25, 2025), LLY annual accounts receivable is $11.01 billion, with the most recent change of +$1.92 billion (+21.07%) on December 31, 2024.
  • During the last 3 years, LLY annual accounts receivable has risen by +$4.33 billion (+64.93%).
  • LLY annual accounts receivable is now at all-time high.

Performance

LLY Accounts receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLLYbalance sheet metrics

Quarterly accounts receivable:

$12.04B+$1.03B(+9.37%)
March 31, 2025

Summary

  • As of today (May 25, 2025), LLY quarterly accounts receivable is $12.04 billion, with the most recent change of +$1.03 billion (+9.37%) on March 31, 2025.
  • Over the past year, LLY quarterly accounts receivable has increased by +$4.15 billion (+52.64%).
  • LLY quarterly accounts receivable is now at all-time high.

Performance

LLY Quarterly accounts receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLLYbalance sheet metrics

Accounts receivable Formula

Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales

LLY Accounts receivable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+21.1%+52.6%
3 y3 years+64.9%+90.4%
5 y5 years+142.0%+135.7%

LLY Accounts receivable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+64.9%at high+90.4%
5 y5-yearat high+142.0%at high+149.3%
alltimeall timeat high+682.7%at high+758.2%

LLY Accounts receivable History

DateAnnualQuarterly
Mar 2025
-
$12.04B(+9.4%)
Dec 2024
$11.01B(+21.1%)
$11.01B(+6.9%)
Sep 2024
-
$10.29B(-6.6%)
Jun 2024
-
$11.03B(+39.8%)
Mar 2024
-
$7.89B(-13.3%)
Dec 2023
$9.09B(+31.8%)
$9.09B(+11.3%)
Sep 2023
-
$8.17B(+8.7%)
Jun 2023
-
$7.52B(-0.1%)
Mar 2023
-
$7.53B(+9.1%)
Dec 2022
$6.90B(+3.3%)
$6.90B(+2.7%)
Sep 2022
-
$6.72B(+5.5%)
Jun 2022
-
$6.36B(+0.7%)
Mar 2022
-
$6.32B(-5.2%)
Dec 2021
$6.67B(+13.6%)
$6.67B(+12.8%)
Sep 2021
-
$5.91B(+1.5%)
Jun 2021
-
$5.83B(+4.2%)
Mar 2021
-
$5.59B(-4.8%)
Dec 2020
$5.88B(+29.2%)
$5.88B(+20.2%)
Sep 2020
-
$4.89B(+1.2%)
Jun 2020
-
$4.83B(-5.4%)
Mar 2020
-
$5.11B(+12.3%)
Dec 2019
$4.55B(-1.0%)
$4.55B(+2.4%)
Sep 2019
-
$4.44B(-3.7%)
Jun 2019
-
$4.61B(+9.8%)
Mar 2019
-
$4.20B(-8.6%)
Dec 2018
$4.59B(+1.0%)
$4.59B(-5.5%)
Sep 2018
-
$4.86B(+0.8%)
Jun 2018
-
$4.82B(+7.3%)
Mar 2018
-
$4.50B(-1.1%)
Dec 2017
$4.55B(+12.8%)
$4.55B(+3.3%)
Sep 2017
-
$4.40B(+1.2%)
Jun 2017
-
$4.35B(+8.3%)
Mar 2017
-
$4.02B(-0.3%)
Dec 2016
$4.03B(+14.7%)
$4.03B(+4.7%)
Sep 2016
-
$3.85B(-2.5%)
Jun 2016
-
$3.95B(+9.0%)
Mar 2016
-
$3.62B(+3.1%)
Dec 2015
$3.51B(+8.6%)
$3.51B(+3.3%)
Sep 2015
-
$3.40B(+1.6%)
Jun 2015
-
$3.35B(+6.6%)
Mar 2015
-
$3.14B(-2.8%)
Dec 2014
$3.23B(-5.8%)
$3.23B(+5.9%)
Sep 2014
-
$3.05B(-4.2%)
Jun 2014
-
$3.19B(+6.2%)
Mar 2014
-
$3.00B(-12.6%)
Dec 2013
$3.43B(+2.9%)
$3.43B(-0.3%)
Sep 2013
-
$3.44B(-3.7%)
Jun 2013
-
$3.58B(+4.1%)
Mar 2013
-
$3.44B(+3.1%)
DateAnnualQuarterly
Dec 2012
$3.34B(-7.3%)
$3.34B(+2.1%)
Sep 2012
-
$3.27B(+2.7%)
Jun 2012
-
$3.18B(-6.5%)
Mar 2012
-
$3.40B(-5.4%)
Dec 2011
$3.60B(+3.0%)
$3.60B(+1.8%)
Sep 2011
-
$3.53B(-7.8%)
Jun 2011
-
$3.83B(+3.8%)
Mar 2011
-
$3.69B(+5.7%)
Dec 2010
$3.49B(+4.5%)
$3.49B(+14.0%)
Jun 2010
-
$3.07B(-4.0%)
Mar 2010
-
$3.19B(-4.5%)
Dec 2009
$3.34B(+20.3%)
$3.34B(+10.8%)
Sep 2009
-
$3.02B(+6.2%)
Jun 2009
-
$2.84B(+6.2%)
Mar 2009
-
$2.68B(-3.7%)
Dec 2008
$2.78B(+3.9%)
$2.78B(+2.8%)
Sep 2008
-
$2.70B(-1.4%)
Jun 2008
-
$2.74B(+2.9%)
Mar 2008
-
$2.66B(-0.5%)
Dec 2007
$2.67B(+16.3%)
$2.67B(+6.3%)
Sep 2007
-
$2.52B(+4.2%)
Jun 2007
-
$2.41B(+7.1%)
Mar 2007
-
$2.25B(-1.9%)
Dec 2006
$2.30B(-0.6%)
$2.30B(+10.6%)
Sep 2006
-
$2.08B(-1.1%)
Jun 2006
-
$2.10B(-0.6%)
Mar 2006
-
$2.11B(-8.6%)
Dec 2005
$2.31B(+12.4%)
$2.31B(+12.4%)
Sep 2005
-
$2.06B(-1.3%)
Jun 2005
-
$2.09B(-1.3%)
Mar 2005
-
$2.11B(+2.6%)
Dec 2004
$2.06B(+10.4%)
$2.06B(+7.6%)
Sep 2004
-
$1.91B(-3.1%)
Jun 2004
-
$1.97B(+3.2%)
Mar 2004
-
$1.91B(+2.5%)
Dec 2003
$1.86B(+11.7%)
$1.86B(+11.9%)
Sep 2003
-
$1.67B(-1.1%)
Jun 2003
-
$1.68B(+1.7%)
Mar 2003
-
$1.66B(-0.9%)
Dec 2002
$1.67B(+18.8%)
$1.67B(+9.5%)
Sep 2002
-
$1.53B(-7.8%)
Jun 2002
-
$1.66B(+10.4%)
Mar 2002
-
$1.50B(+6.6%)
Dec 2001
$1.41B(-28.5%)
$1.41B(+0.3%)
Sep 2001
-
$1.40B(-7.8%)
Jun 2001
-
$1.52B(+3.4%)
Mar 2001
-
$1.47B(-25.2%)
Dec 2000
$1.97B(+6.7%)
$1.97B(+6.7%)
Dec 1999
$1.84B(+6.1%)
$1.84B(+6.1%)
Dec 1996
$1.74B
$1.74B

FAQ

  • What is Eli Lilly and Company annual accounts receivable?
  • What is the all time high annual accounts receivable for Eli Lilly and Company?
  • What is Eli Lilly and Company annual accounts receivable year-on-year change?
  • What is Eli Lilly and Company quarterly accounts receivable?
  • What is the all time high quarterly accounts receivable for Eli Lilly and Company?
  • What is Eli Lilly and Company quarterly accounts receivable year-on-year change?

What is Eli Lilly and Company annual accounts receivable?

The current annual accounts receivable of LLY is $11.01B

What is the all time high annual accounts receivable for Eli Lilly and Company?

Eli Lilly and Company all-time high annual accounts receivable is $11.01B

What is Eli Lilly and Company annual accounts receivable year-on-year change?

Over the past year, LLY annual accounts receivable has changed by +$1.92B (+21.07%)

What is Eli Lilly and Company quarterly accounts receivable?

The current quarterly accounts receivable of LLY is $12.04B

What is the all time high quarterly accounts receivable for Eli Lilly and Company?

Eli Lilly and Company all-time high quarterly accounts receivable is $12.04B

What is Eli Lilly and Company quarterly accounts receivable year-on-year change?

Over the past year, LLY quarterly accounts receivable has changed by +$4.15B (+52.64%)
On this page